Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, January 17, 2022.
NovaBay Pharmaceuticals, Inc. (AMEX:NBY)
Long-Term Downtrend (-90) - NBY is in a strong downtrend that is likely to continue. While NBY is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid NBY?
MarketClub looks at technical strength and momentum to determine if the timing is right for NBY.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NBY
The long-term trend has been DOWN since May 10th, 2021 at 0.71
The intermediate-term trend has been DOWN since Dec 28th, 2021 at 0.40
The short-term trend has been DOWN since Jan 6th, 2022 at 0.37
Smart Scan Analysis for NBY
Based on our trend formula, NBY is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.3500 | 0.3549 | 0.3340 | 0.3427 | -0.0005 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.3438 | 536669 | 2022-01-14 15:59:55 |
| Year High | 4.2 | Year High Date | 2018-01-02 |
| Year Low | 0.9659 | Year Low Date | 2018-11-06 |
| 52wk High | 1.79 | 52wk High Date | 2021-02-18 |
| 52wk Low | 0.3405 | 52wk Low Date | 2022-01-13 |
| Year End Close | 1.13 | Average Volume | 982,574 |
| Shares Outstanding | 44,943 | Short Interest | 1,099,006 |
| % Institutional | 16.8 | Market Cap | 9M |
| Assets | 12,239,000M | Liabilities | 2,875,000M |
| P/E Ratio | -2.3226 | Beta | 0.99 |
| Volatility | 80.83 |